We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CNC vs. HUM: Which Stock Is the Better Value Option?
Read MoreHide Full Article
Investors interested in stocks from the Medical - HMOs sector have probably already heard of Centene (CNC - Free Report) and Humana (HUM - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Right now, Centene is sporting a Zacks Rank of #2 (Buy), while Humana has a Zacks Rank of #4 (Sell). Investors should feel comfortable knowing that CNC likely has seen a stronger improvement to its earnings outlook than HUM has recently. But this is just one piece of the puzzle for value investors.
Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.
Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.
CNC currently has a forward P/E ratio of 8.30, while HUM has a forward P/E of 15.85. We also note that CNC has a PEG ratio of 0.72. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. HUM currently has a PEG ratio of 1.92.
Another notable valuation metric for CNC is its P/B ratio of 1.05. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, HUM has a P/B of 1.90.
These metrics, and several others, help CNC earn a Value grade of A, while HUM has been given a Value grade of C.
CNC has seen stronger estimate revision activity and sports more attractive valuation metrics than HUM, so it seems like value investors will conclude that CNC is the superior option right now.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
CNC vs. HUM: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - HMOs sector have probably already heard of Centene (CNC - Free Report) and Humana (HUM - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Right now, Centene is sporting a Zacks Rank of #2 (Buy), while Humana has a Zacks Rank of #4 (Sell). Investors should feel comfortable knowing that CNC likely has seen a stronger improvement to its earnings outlook than HUM has recently. But this is just one piece of the puzzle for value investors.
Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.
Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.
CNC currently has a forward P/E ratio of 8.30, while HUM has a forward P/E of 15.85. We also note that CNC has a PEG ratio of 0.72. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. HUM currently has a PEG ratio of 1.92.
Another notable valuation metric for CNC is its P/B ratio of 1.05. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, HUM has a P/B of 1.90.
These metrics, and several others, help CNC earn a Value grade of A, while HUM has been given a Value grade of C.
CNC has seen stronger estimate revision activity and sports more attractive valuation metrics than HUM, so it seems like value investors will conclude that CNC is the superior option right now.